Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Patients with atopic dermatitis dosed in phase I trial of MOR-106

Sep. 30, 2016

Marketing approval for Galderma's Epiduo given by several European regulatory bodies

Sep. 29, 2016

Shire terminates collaboration agreement with Momenta Pharmaceuticals for M-923

Sep. 28, 2016

Lumicef set for first global launch in Japan this month

Sep. 28, 2016

Pilot study finds significant hair regrowth with ruxolitinib in alopecia areata

Sep. 28, 2016

FDA accepts for priority review dupilumab BLA for atopic dermatitis

Sep. 26, 2016

Genfit validates RORgammat inverse agonist drug candidates for pre-IND studies

Sep. 23, 2016

Kadmon initiates phase II trials of KD-025 in psoriasis and GvHD

Sep. 22, 2016

Nitto Denko patents carboxylesterase inhibitors

Sep. 16, 2016

GSK initiates phase II trial of GSK-2982772 in psoriasis

Sep. 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026